Swedish Orphan Biovitrum AB (publ) (SWOBY) Discusses on NASP and Uncontrolled Gout Call
Seeking Alphaยท2025-09-17 21:17
PresentationGuido OelkersCEO & President Hello, everyone. This is Guido Oelkers, CEO of Sobi. We are delighted to welcome you to this call to discuss the NASP program after we have just received the acceptance of the filing package with FDA for uncontrolled gout. Please turn to Slide 2. We would like to remind you of the usual provisions on statements about expectations and projections of future events. With this said, please turn to Slide 3. I'm very pleased to have Dr. Herbert Baraf joining us today. He i ...